Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 658 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1,238 | N/A | N/A | N/A | N/A |
| Gross Profit | -580 | N/A | N/A | N/A | N/A |
| Operating Expenses | 8,296 | 9,706 | 11,061 | 10,862 | -2,282 |
| Operating Income | -8,638 | -9,706 | -11,061 | -10,862 | 2,282 |
| Interest Expense | 1,325 | -3,206 | 0 | 0 | 4,863 |
| Other Income | 14,759 | 0 | 5,265 | 2,656 | 1,195 |
| Pre-tax Income | 4,796 | -6,500 | -5,796 | -8,206 | -1,386 |
| Net Income Continuous | 4,796 | -6,500 | -5,796 | -8,206 | -1,386 |
| Net Income | $4,796 | $-6,500 | $-5,796 | $-8,206 | $-1,386 |
| EPS Basic Total Ops | 0.00 | -16.00 | -40.00 | -58.16 | -12.00 |
| EPS Basic Continuous Ops | 5.95 | -16.64 | -30.75 | -58.16 | -12.51 |
| EPS Diluted Total Ops | 0.00 | -16.00 | -40.00 | -58.16 | -12.00 |
| EPS Diluted Continuous Ops | 5.95 | -16.64 | -30.75 | -58.16 | -12.51 |
| EPS Diluted Before Non-Recurring Items | -5.95 | -166.40 | -40.00 | -80.00 | -12.00 |
| EBITDA(a) | $-6,989 | $-9,192 | $-10,499 | $-10,391 | $3,040 |